Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Targeted treatment of non-small cell lung cancer]Matthias Scheffler, Sebastian Michels, Lucia Nogova
The AAPS Journal|February 14, 2013
Modeling NSCLC progression: recent advances and opportunities availableAhmed Abbas Suleiman, Lucia Nogova, Uwe Fuhr
Innere Medizin (Heidelberg, Germany)|October 17, 2025
[Treatment of metastatic non-small cell lung cancer]Malte Verheyen, Lea Ruge, Felix John, et al.
Translational Lung Cancer Research|March 26, 2015
FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implicationsHans-Ulrich Schildhaus, Lucia Nogova, Jürgen Wolf, et al.
Blood|September 25, 2007
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)Michal Sieniawski, Thorsten Reineke, Lucia Nogova, et al.
Journal of Medical Case Reports|June 1, 2011
Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case reportAlexander Shimabukuro-Vornhagen, Achim Rothe, Lucia Nogova, et al.
Heliyon|December 27, 2023
Efficiency of B-RAF-/MEK-inhibitors in B-RAF mutated Ameloblastoma: Case report and review of literatureReinhard Büttner, Sibel Elif Gültekin, Carina Heydt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007
Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphomaMichal Sieniawski, Jeremy Franklin, Lucia Nogova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2004
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study GroupHenning Bredenfeld, Jeremy Franklin, Lucia Nogova, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2012
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PETMatthias Scheffler, Carsten Kobe, Thomas Zander, et al.
Pageof 5